Discovery of Orally Efficacious Tetrahydrobenzimidazoles as TGR5 Agonists for Type 2 Diabetes.
Zhang X, Wall M, Sui Z, Kauffman J, Hou C, Chen C, Du F, Kirchner T, Liang Y, Johnson DL, Murray WV, Demarest K.
Zhang X, et al. Among authors: liang y.
ACS Med Chem Lett. 2017 Apr 21;8(5):560-565. doi: 10.1021/acsmedchemlett.7b00116. eCollection 2017 May 11.
ACS Med Chem Lett. 2017.
PMID: 28523111
Free PMC article.